Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - ACCOUNTS PAYABLE
Accounts Payable RARE - Ultragenyx Pharmaceutical Inc.
42.1 M
LAST VALUE
56.76%
2 YEAR CAGR
27.96%
5 YEAR CAGR
40.18%
10 YEAR CAGR